Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 1446194 BALA CYNWYD, PA

Position in RGC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$140,855
+$140,855 QoQ
Shares Held
23,129
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 35 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Derivatives in RGC

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$290,493
PutShares
47,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. RGC ranks #42 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGC

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,855 23,129
2026-06-30 $290,493 47,700
2026-03-31 $859,534 33,800
2026-03-31 $989,227 38,900
2025-12-31 $554,400 26,400
2025-12-31 $787,500 37,500
2025-09-30 $639,630 41,400
2025-09-30 $964,080 62,400